Allergic rhinitis: an update on disease, present treatments and future prospects.
about
Medical history, lifestyle, family history, and occupational risk factors for mantle cell lymphoma: the InterLymph Non-Hodgkin Lymphoma Subtypes ProjectInhibition of IL-32 signaling by bamboo salt decreases pro-inflammatory responses in cellular models of allergic rhinitisSingle- and multiple-dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects.Anti-allergic effect of a Korean traditional medicine, Biyeom-Tang on mast cells and allergic rhinitis.Allergic rhinitis, rhinoconjunctivitis and hayfever symptoms among children are associated with frequency of truck traffic near residences: a cross sectional study.Allergen-Dependent Differences in ILC2s Frequencies in Patients With Allergic RhinitisEfficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies.Role of leukotriene antagonists and antihistamines in the treatment of allergic rhinitis.Omalizumab for treatment of allergic rhinitis.A topical microemulsion for the prevention of allergic rhinitis symptoms: results of a randomized, controlled, double-blind, parallel group, multicentre, multinational clinical trial (Nares study).2-(4-{2-[(phenylthio)acetyl]carbonohydrazonoyl}phenoxy)acetamide as a new lead compound for management of allergic rhinitis.The antiallergic mechanisms of Citrus sunki and bamboo salt (K-ALL) in an allergic rhinitis model.Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by T-box protein expressed in T cells/GATA-3 and forkhead box protein 3/retinoic acid-related orphan nuclear receptor γt.Design of Phthalazinone Amide Histamine H1 Receptor Antagonists for Use in Rhinitis.Different FCER1A polymorphisms influence IgE levels in asthmatics and non-asthmatics.Biyuanling suppresses the toluene-2, 4-diisocyanate induced allergic rhinitis in guinea pigs.Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects.
P2860
Q28393760-F155F692-0C96-426D-A830-53AB70E76B15Q34124598-C51BC4A2-7C2F-484A-A02A-A51B6B01BE36Q34415322-D23A7E16-A7C3-4616-9899-1EC81633D352Q35093070-E9648A55-049C-41BE-84ED-DA10B5906299Q36206350-AD775EFD-E06A-4D7E-B1C1-D0EA7B7E5B48Q36636578-48F6872C-7F93-48CD-80CD-9993F3998B10Q37736669-EEB7E3C6-45B4-4D7F-A580-F628DCC5BB9CQ38079750-72908F96-B92A-4D76-A048-0D3F1B33D4DEQ38101972-D0FB880C-8D7D-4EC9-9C83-D340293ECBF4Q38445599-D69CAB69-FA4D-47CC-9CA9-344497D0825CQ38739017-195DA903-A4E1-4727-B484-C41BE3886BD8Q39077794-15B7C141-BC2C-402B-BAF9-675C49C7EEABQ42347155-F533A835-26C4-4BB7-AABC-85B64D788E9CQ47887056-22BC55CD-FAA0-4F00-B0A8-C268076435EBQ50947108-B3BD6916-799C-4E6E-9564-8AF4CFACEE0EQ53699889-C49FF52D-2C58-459B-AA28-298C4BB020D5Q54292936-C255903B-5F4C-4F5C-9E1C-8378FEEF3AD7
P2860
Allergic rhinitis: an update on disease, present treatments and future prospects.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Allergic rhinitis: an update on disease, present treatments and future prospects.
@en
Allergic rhinitis: an update on disease, present treatments and future prospects.
@nl
type
label
Allergic rhinitis: an update on disease, present treatments and future prospects.
@en
Allergic rhinitis: an update on disease, present treatments and future prospects.
@nl
prefLabel
Allergic rhinitis: an update on disease, present treatments and future prospects.
@en
Allergic rhinitis: an update on disease, present treatments and future prospects.
@nl
P2093
P1476
Allergic rhinitis: an update on disease, present treatments and future prospects.
@en
P2093
Jigar H Shah
Rajamannar Thennati
Sanjay N Mandhane
P304
P356
10.1016/J.INTIMP.2011.07.005
P577
2011-07-23T00:00:00Z